Agilon Health (AGL) Cost of Revenue (2020 - 2026)

Agilon Health (AGL) has 7 years of Cost of Revenue data on file, last reported at $367.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 914.56% year-over-year to $367.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.3 billion (up 121.17% YoY), and the FY2025 full-year result was $6.0 billion, up 74623.82% from the prior year.
• Cost of Revenue for Q1 2026 stood at $367.7 million, down from $5.9 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $5.9 billion in Q4 2025 and bottomed at -$63.5 million in Q4 2024.
• The 5-year median for Cost of Revenue is $367.7 million (2026), against an average of $992.8 million.
• The widest annual swing landed in 2024, when Cost of Revenue slumped 101.61%; it then surged 9377.3% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $847.1 million in 2022, then soared by 364.85% to $3.9 billion in 2023, then plunged by 101.61% to -$63.5 million in 2024, then soared by 9377.3% to $5.9 billion in 2025, then tumbled by 93.76% to $367.7 million in 2026.
• The last three Cost of Revenue figures came in at $367.7 million (Q1 2026), $5.9 billion (Q4 2025), and $33.7 million (Q3 2025), per Business Quant data.

Peer Comparison